Ontology type: schema:ScholarlyArticle Open Access: True
2017-10
AUTHORSMasayuki Shiseki, Chikashi Yoshida, Naoki Takezako, Akira Ohwada, Takashi Kumagai, Kaichi Nishiwaki, Akira Horikoshi, Tetsuya Fukuda, Hina Takano, Yasuji Kouzai, Junji Tanaka, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi
ABSTRACTBACKGROUND: With the introduction of imatinib, a first-generation tyrosine kinase inhibitor (TKI) to inhibit BCR-ABL1 kinase, the outcome of chronic-phase chronic myeloid leukemia (CP-CML) has improved dramatically. However, only a small proportion of CP-CML patients subsequently achieve a deep molecular response (DMR) with imatinib. Dasatinib, a second-generation TKI, is more potent than imatinib in the inhibition of BCR-ABL1 tyrosine kinase in vitro and more effective in CP-CML patients who do not achieve an optimal response with imatinib treatment. METHODS: In the present study, we attempted to investigate whether switching the treatment from imatinib to dasatinib can induce DMR in 16 CP-CML patients treated with imatinib for at least two years who achieved a major molecular response (MMR) with detectable levels of BCR-ABL1 transcripts. RESULTS: The rates of achievement of DMR at 1, 3, 6 and 12 months after switching to dasatinib treatment in the 16 patients were 44% (7/16), 56% (9/16), 63% (10/16) and 75% (12/16), respectively. The cumulative rate of achieving DMR at 12 months from initiation of dasatinib therapy was 93.8% (15/16). The proportion of natural killer cells and cytotoxic T cells in peripheral lymphocytes increased after switching to dasatinib. In contrast, the proportion of regulatory T cells decreased during treatment. The safety profile of dasatinib was consistent with previous studies. CONCLUSION: Switching to dasatinib would be a therapeutic option for CP-CML patients who achieved MMR but not DMR by imatinib, especially for patients who wish to discontinue TKI therapy. More... »
PAGES972-979
http://scigraph.springernature.com/pub.10.1007/s10147-017-1141-y
DOIhttp://dx.doi.org/10.1007/s10147-017-1141-y
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1085600783
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/28550414
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dasatinib",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Fusion Proteins, bcr-abl",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gene Expression Regulation, Leukemic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Imatinib Mesylate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Killer Cells, Natural",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myeloid, Chronic-Phase",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mutation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Protein Kinase Inhibitors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Tokyo Women's Medical University",
"id": "https://www.grid.ac/institutes/grid.410818.4",
"name": [
"Department of Hematology, Tokyo Women\u2019s Medical University, 8-1 Kawadacho, Shinjuku-ku, 162-8666, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Shiseki",
"givenName": "Masayuki",
"id": "sg:person.01160354044.92",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160354044.92"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Mito Medical Center",
"id": "https://www.grid.ac/institutes/grid.410845.c",
"name": [
"Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan"
],
"type": "Organization"
},
"familyName": "Yoshida",
"givenName": "Chikashi",
"id": "sg:person.01277156611.63",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277156611.63"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "National Disaster Medical Center",
"id": "https://www.grid.ac/institutes/grid.416797.a",
"name": [
"Department of Hematology, National Disaster Medical Center, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Takezako",
"givenName": "Naoki",
"id": "sg:person.01255632675.62",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255632675.62"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Metropolitan Bokutoh Hospital",
"id": "https://www.grid.ac/institutes/grid.414532.5",
"name": [
"Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Ohwada",
"givenName": "Akira",
"id": "sg:person.01105713660.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105713660.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ome Municipal General Hospital",
"id": "https://www.grid.ac/institutes/grid.416773.0",
"name": [
"Department of Hematology, Ohme Municipal General Hospital, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Kumagai",
"givenName": "Takashi",
"id": "sg:person.0677442365.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677442365.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Jikei University Kashiwa hospital",
"id": "https://www.grid.ac/institutes/grid.470101.3",
"name": [
"Clinical Oncology and Hematology, Jikei University Kashiwa Hospital, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Nishiwaki",
"givenName": "Kaichi",
"id": "sg:person.01016710710.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016710710.32"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Department of General Internal Medicine, Nerima-Hikarigaoka Hospital, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Horikoshi",
"givenName": "Akira",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Medical and Dental University",
"id": "https://www.grid.ac/institutes/grid.265073.5",
"name": [
"Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Fukuda",
"givenName": "Tetsuya",
"id": "sg:person.011410526632.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011410526632.25"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Department of Hematology, Japanese Red Cross Musashino Hospital, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Takano",
"givenName": "Hina",
"id": "sg:person.0737601106.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737601106.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Metropolitan Tama Medical Center",
"id": "https://www.grid.ac/institutes/grid.417089.3",
"name": [
"Hematology Department, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Kouzai",
"givenName": "Yasuji",
"id": "sg:person.01306514715.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306514715.51"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Women's Medical University",
"id": "https://www.grid.ac/institutes/grid.410818.4",
"name": [
"Department of Hematology, Tokyo Women\u2019s Medical University, 8-1 Kawadacho, Shinjuku-ku, 162-8666, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Tanaka",
"givenName": "Junji",
"id": "sg:person.0714107337.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714107337.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Kyoto University",
"id": "https://www.grid.ac/institutes/grid.258799.8",
"name": [
"Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan"
],
"type": "Organization"
},
"familyName": "Morita",
"givenName": "Satoshi",
"id": "sg:person.01177506722.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177506722.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokai Central Hospital",
"id": "https://www.grid.ac/institutes/grid.460103.0",
"name": [
"Tokai Central Hospital, Gifu, Japan"
],
"type": "Organization"
},
"familyName": "Sakamoto",
"givenName": "Junichi",
"id": "sg:person.0673305153.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673305153.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Metropolitan Komagome Hospital",
"id": "https://www.grid.ac/institutes/grid.415479.a",
"name": [
"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Sakamaki",
"givenName": "Hisashi",
"id": "sg:person.01143751601.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143751601.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nippon Medical School",
"id": "https://www.grid.ac/institutes/grid.410821.e",
"name": [
"Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Inokuchi",
"givenName": "Koiti",
"id": "sg:person.015546543462.29",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015546543462.29"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s10147-011-0328-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002300629",
"https://doi.org/10.1007/s10147-011-0328-x"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/ajh.24120",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003406138"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/ajh.23560",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007808876"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2403898",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009272053",
"https://doi.org/10.1038/sj.leu.2403898"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2403898",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009272053",
"https://doi.org/10.1038/sj.leu.2403898"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3324/haematol.2011.056853",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010248133"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1074/jbc.m109.090043",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010587868"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2013.49.9020",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010959241"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2009.46",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012226579",
"https://doi.org/10.1038/leu.2009.46"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2013-12-544015",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015702726"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2011-08-376087",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016192910"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa062867",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018371941"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.leukres.2014.04.004",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018902032"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1600-0609.2010.01501.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019128754"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(10)70233-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022333795"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2010-03-273979",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023043587"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2013-02-483750",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024310337"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(11)70201-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025925789"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3324/haematol.2013.095158",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026297082"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.leukres.2010.12.006",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026344073"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2012.104",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028787105",
"https://doi.org/10.1038/leu.2012.104"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-013-1483-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029623849",
"https://doi.org/10.1007/s12185-013-1483-9"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3324/haematol.13151",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030376624"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1002315",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031069177"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.clml.2016.02.002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033799121"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2007-06-093617",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033965576"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-642-01222-8_14",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033999680",
"https://doi.org/10.1007/978-3-642-01222-8_14"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2009-12-256800",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034134856"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ddtec.2014.03.003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034288698"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-05-0259",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034468291"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/ejh.12423",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035929186"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2013-05-501569",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037386922"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2010.16",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037877544",
"https://doi.org/10.1038/leu.2010.16"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2010.16",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037877544",
"https://doi.org/10.1038/leu.2010.16"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s2352-3026(15)00196-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039925779"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2007-10-116236",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041036031"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2010.185",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043258932",
"https://doi.org/10.1038/leu.2010.185"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa0912614",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044250877"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2006-09-047266",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045739244"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/ajh.24096",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046998802"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.14.9260",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047846528"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-010-0565-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049319668",
"https://doi.org/10.1007/s12185-010-0565-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-010-0565-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049319668",
"https://doi.org/10.1007/s12185-010-0565-1"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2004-08-3097",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049798624"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/ajh.23427",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050522743"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.7326/m15-2306",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1073742882"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1078153270",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.6004/jnccn.2014.0159",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1078996826"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.6004/jnccn.2014.0159",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1078996826"
],
"type": "CreativeWork"
}
],
"datePublished": "2017-10",
"datePublishedReg": "2017-10-01",
"description": "BACKGROUND: With the introduction of imatinib, a first-generation tyrosine kinase inhibitor (TKI) to inhibit BCR-ABL1 kinase, the outcome of chronic-phase chronic myeloid leukemia (CP-CML) has improved dramatically. However, only a small proportion of CP-CML patients subsequently achieve a deep molecular response (DMR) with imatinib. Dasatinib, a second-generation TKI, is more potent than imatinib in the inhibition of BCR-ABL1 tyrosine kinase in vitro and more effective in CP-CML patients who do not achieve an optimal response with imatinib treatment.\nMETHODS: In the present study, we attempted to investigate whether switching the treatment from imatinib to dasatinib can induce DMR in 16 CP-CML patients treated with imatinib for at least two years who achieved a major molecular response (MMR) with detectable levels of BCR-ABL1 transcripts.\nRESULTS: The rates of achievement of DMR at 1, 3, 6 and 12\u00a0months after switching to dasatinib treatment in the 16 patients were 44% (7/16), 56% (9/16), 63% (10/16) and 75% (12/16), respectively. The cumulative rate of achieving DMR at 12\u00a0months from initiation of dasatinib therapy was 93.8% (15/16). The proportion of natural killer cells and cytotoxic T cells in peripheral lymphocytes increased after switching to dasatinib. In contrast, the proportion of regulatory T cells decreased during treatment. The safety profile of dasatinib was consistent with previous studies.\nCONCLUSION: Switching to dasatinib would be a therapeutic option for CP-CML patients who achieved MMR but not DMR by imatinib, especially for patients who wish to discontinue TKI therapy.",
"genre": "research_article",
"id": "sg:pub.10.1007/s10147-017-1141-y",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1312225",
"issn": [
"1341-9625",
"1437-7772"
],
"name": "International Journal of Clinical Oncology",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "22"
}
],
"name": "Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy",
"pagination": "972-979",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"e91676c2a583f18d07cee859f268199724b1803fb6cf677800273d59cb7f95ec"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"28550414"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9616295"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10147-017-1141-y"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1085600783"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10147-017-1141-y",
"https://app.dimensions.ai/details/publication/pub.1085600783"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T10:33",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113658_00000004.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1007%2Fs10147-017-1141-y"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10147-017-1141-y'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10147-017-1141-y'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10147-017-1141-y'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10147-017-1141-y'
This table displays all metadata directly associated to this object as RDF triples.
410 TRIPLES
21 PREDICATES
90 URIs
37 LITERALS
25 BLANK NODES